These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 23225658)
1. Retrograde CTO recanalization of RCA SVG from the contralateral LAD SVG: "coast to coast" revascularization with FFR in between. Kern MJ Catheter Cardiovasc Interv; 2012 Dec; 80(7):1216-7. PubMed ID: 23225658 [No Abstract] [Full Text] [Related]
2. Retrograde fractional flow reserve and recanalization of a chronic total occlusion of a saphenous venous graft. Singla S; Uretsky BF; Sachdeva R Catheter Cardiovasc Interv; 2012 Dec; 80(7):1210-5. PubMed ID: 22121036 [TBL] [Abstract][Full Text] [Related]
3. Staged revascularization in patients with acute coronary syndromes due to saphenous vein graft failure and chronic total occlusion of the native vessel: A novel concept. Xenogiannis I; Tajti P; Burke MN; Brilakis ES Catheter Cardiovasc Interv; 2019 Feb; 93(3):440-444. PubMed ID: 30461165 [TBL] [Abstract][Full Text] [Related]
4. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques. Al-Lamee R; Ielasi A; Latib A; Godino C; Ferraro M; Arioli F; Mussardo M; Piraino D; Figini F; Carlino M; Montorfano M; Chieffo A; Colombo A Am J Cardiol; 2010 Dec; 106(12):1721-7. PubMed ID: 21126616 [TBL] [Abstract][Full Text] [Related]
9. Successful Revascularization of an LCx CTO Lesion by Retrograde Approach From an Acute Thrombotic SVG Without Protection Device in an ACS Patient. Lin MM; Wang JH Int Heart J; 2016 May; 57(3):372-5. PubMed ID: 27170471 [TBL] [Abstract][Full Text] [Related]
10. Management of SVG disease: are we missing the point (and an opportunity)? Safian RD Catheter Cardiovasc Interv; 2012 May; 79(6):919-20. PubMed ID: 22511378 [No Abstract] [Full Text] [Related]
11. Current percutaneous treatment strategies for saphenous vein graft disease. Marmagkiolis K; Grines C; Bilodeau L Catheter Cardiovasc Interv; 2013 Sep; 82(3):406-13. PubMed ID: 22777812 [TBL] [Abstract][Full Text] [Related]
12. Saphenous vein graft recanalization without embolic protection: impossible is nothing. Belardi JA; Albertal M Catheter Cardiovasc Interv; 2011 Jul; 78(1):70-1. PubMed ID: 21681894 [No Abstract] [Full Text] [Related]
13. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era. Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913 [TBL] [Abstract][Full Text] [Related]
14. Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program. Brilakis ES; Lasala JM; Cox DA; Berger PB; Bowman TS; Starzyk RM; Dawkins KD JACC Cardiovasc Interv; 2010 Jul; 3(7):742-50. PubMed ID: 20650436 [TBL] [Abstract][Full Text] [Related]
15. Aspiration of a mobile thromboembolus from saphenous vein graft. Cohen HM; Kleiman JH Cathet Cardiovasc Diagn; 1992 Sep; 27(1):49-51. PubMed ID: 1525810 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of Fractional Flow Reserve-Based Deferral in Saphenous Vein Graft Narrowing. Almomani A; Pothineni NV; Edupuganti M; Payne J; Agarwal S; Uretsky B; Hakeem A Am J Cardiol; 2018 Sep; 122(5):723-728. PubMed ID: 30064860 [TBL] [Abstract][Full Text] [Related]